Enhanced tuberculosis identification through 1-month follow-up of smear-negative tuberculosis suspects
SETTING: Bandim Health Project, Bissau, Guinea-Bissau.OBJECTIVE: To conduct tuberculosis (TB) screening among former TB suspects in whom TB had been ruled out on initial consultation and therefore assumed to be TB-negative (aTBneg).DESIGN: In a cohort follow-up study, 'aTBneg suspects' wer...
Gespeichert in:
Veröffentlicht in: | The international journal of tuberculosis and lung disease 2011-04, Vol.15 (4), p.459-464 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | SETTING: Bandim Health Project, Bissau, Guinea-Bissau.OBJECTIVE: To conduct tuberculosis (TB) screening among former TB suspects in whom TB had been ruled out on initial consultation and therefore assumed to be TB-negative (aTBneg).DESIGN: In a cohort follow-up study, 'aTBneg
suspects' were screened for symptoms from 1 month after the initial negative sputum smear examination. Symptomatic individuals were referred for clinical re-examination and human immunodeficiency virus (HIV) testing.RESULTS: Among 428 TB suspects presenting over a 10-month period
in 2007, 80% (343) were smear-negative. Of these, 21 were subsequently diagnosed with smear-negative TB. Of the remaining 322 aTBneg patients, 212 were followed up and symptoms were examined ≥1 month after initial examination. Among followed up patients, 89 (42%) were still symptomatic:
five were diagnosed with TB on the basis of repeated sputum smears and chest X-ray. Of 44 symptomatic patients, 39% (n = 17) were HIV-infected. Thirteen (4%) of the 322 aTBneg suspects died before follow-up.CONCLUSION: A large proportion of aTBneg patients remained symptomatic
after 1 month. Several TB cases had initially not been diagnosed, and HIV infection was highly prevalent. aTBneg suspects have a high mortality rate and need increased attention from both TB and HIV programmes. |
---|---|
ISSN: | 1027-3719 1815-7920 |
DOI: | 10.5588/ijtld.10.0353 |